Christopher Ryan Sullivan, CFO: Avalo Therapeutics AVTX Buy · Filed 23/06/13

Trade details

Type: Insider buy
Amount: $1,747.62
Shares · price: 511 sh · $3.42 a share
Held after: 1,262 sh
Stock: Avalo Therapeutics AVTX
Person: Christopher Ryan SullivanCFO
Trade date: 23/06/09
Filed: 23/06/13
Days to filing: 4 days

3 insiders bought this week

Insiders buying this week: 3 insiders
Holding change: +68.0%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Christopher Ryan Sullivan's recent trades

Christopher Ryan SullivanCFO
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$622.2K
31,031 sh
$622.2K
Filed 08/18
Traded 08/18
Christopher Ryan SullivanCFO
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$1.4M
70,709 sh
$1.4M
Filed 08/17
Traded 08/17
Christopher Ryan SullivanCFO
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$74.8K
3,749 sh
$74.8K
Filed 08/17
Traded 08/17
Christopher Ryan SullivanCFO
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$448.8K
18,606 sh
$448.8K
Filed 05/11
Traded 05/07
Christopher Ryan SullivanCFO
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$405.8K
18,606 sh
$405.8K
Filed 05/07
Traded 05/07